BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Hangzhou Highlightll Pharmaceutical Co. Ltd.

Headquarters: Hangzhou, China
Year Founded: 2017
Status: Private

BioCentury | Dec 21, 2023
Finance

Dec. 20 Quick Takes: CNS and topical TYK2 inhibitor company Sudo raises $116M series B

Plus: Dynamk’s Kranjac launches new equity firm, PureTech reveals newcos and updates from bluebird, Calliditas and Merck 
BioCentury | Nov 9, 2023
Deals

China’s strength is innovation on innovation. Western partners are lining up

Deep antibody expertise is a platform for leaps in new assets and technologies as Asia biotechs become increasingly competitive
BioCentury | Mar 23, 2023
Deals

March 23 Quick Takes: Moderna, Generation Bio in non-viral genetic medicines pact

Plus: PureTech sells royalty for Karuna’s schizophrenia asset and updates from Dewpoint, Novo Nordisk, Gilead and more
BioCentury | Jul 3, 2021
Emerging Company Profile

Hangzhou Highlightll: Twice the target, hold the tox

TYK2/JAK1 inhibitor could treat a broad range of autoimmune diseases
Items per page:
1 - 4 of 4